Global Pharmaceutical Softgel Capsules Market, By Type (Gelatin Softgel Capsules, Vegetarian Softgel Capsules), Application (Antacid & Antiflatulent Preparations, Ophthalmic Softgel Capsules, Anti-inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cardiovascular Therapy Drugs, Health Supplements, and Others), End-Users (Clinics, Hospitals, Home Care), Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights: Global Pharmaceutical Softgel Capsules Market
Pharmaceutical softgel capsules market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a CAGR of 5.50% in the above-mentioned research forecast period. Rising application of softgel capsules in nutraceutical industries and increasing investment by major market players in capsule manufacturing plants.
Development of smart capsules for efficient drug delivery and rise in consumer awareness related to preventive healthcare and proliferation of distribution channel also boost up the market growth. Moreover, increasing research and development and increasing government support act as opportunity for the market growth. But, sometimes high cost of vegetarian capsules, stringent regulations, patent constrains and fluctuating price of raw materials may hamper the global pharmaceutical softgel capsules market.
A soft gelatin capsules is a solid capsule that encapsulates the inner liquid and semi solid filling. The amount of drug with or without adjuvant is enclosed within the sealed elastic cover. Softgel allows better delivery of drug constituents as it contains the active ingredient in solutions, emulsion which offers better absorption s compared to that of the powder and tablet forms. Pharmaceutical softgels are coated with the suitable exterior coating agents involving cellulose acetate phthalate so as to ensure the enteric release of encapsulated drug material.
The standard shape of pharmaceutical softgel is oval, oblong and round. Moreover softgel possess aesthetic properties and can be swallowed easily which makes them highly consumable in the capsules market. Most common flavouring agents used for softgel preparation includes ethyl vanillin, essential oils, and different sugar mainly sucrose.
As the demand of efficient drug delivery system is increasing worldwide along with better taste and easily chewable property, the continuous research and development in softgel capsules hence expected to provide market with the lucrative growth. It is also estimated that pharmaceutical softgel capsules market is growing with the CAGR of 5.50% in 2020.
This pharmaceutical softgel capsules market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Global Pharmaceutical Softgel Capsules Market Scope and Market Size
Pharmaceutical softgel capsules market is segmented on the basis of type, application, end-users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of type, the pharmaceutical softgel capsules market is segmented into gelatin softgel capsules, vegetarian softgel capsules.
- On the basis of application, the pharmaceutical softgel capsules market is segmented into antacid & antiflatulent preparations, ophthalmic softgel capsules, anti-inflammatory drugs, antibiotic & antibacterial drugs, cardiovascular therapy drugs, health supplements, and others.
- On the basis of end-users, the pharmaceutical softgel capsules market is segmented into clinics, hospitals, home care.
- On the basis of distribution channel, the pharmaceutical softgel capsules market has also been segmented into direct tender, hospital pharmacy, retail pharmacy, online pharmacy and others.
Pharmaceutical Softgel Capsules Market Country Level Analysis
Pharmaceutical softgel capsules market is analysed and market size information is provided by country, type, application, end-users and distribution channel as referenced above.
The countries covered in the pharmaceutical softgel capsules market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.
North America accounts the largest market share due to the presence of high healthcare expenditure and increasing research and development. Europe accounts the second largest market share due to presence of wide distribution network for pharmaceutical softgel capsules. Asia-Pacific is expected to account for the largest market share over coming years for the pharmaceutical softgel capsules market due increasing chronic diseases with the increasing demand of efficient drug delivery system.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Pharmaceutical softgel capsules market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Pharmaceutical Softgel Capsules Market Share Analysis
Pharmaceutical softgel capsules market competitive landscape provides details by competitor. details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to pharmaceutical softgel capsules market.
The major players covered in the pharmaceutical softgel capsules market are Catalent, Inc, Thermo Fisher Scientific Inc., Capsugel, CAPTEK, Eurocaps Ltd., Amway, Sirio Pharma Co., Ltd., Strides Pharma Science Limited, INTERNATIONAL VITAMIN CORPORATION, Weihai Baihe Biology Technological Co., Ltd., Yuwang, Aenova Holding GmbH, Softgel Healthcare, Douglas Laboratories, MEDGEL., Softcaps (Titanium Technologies India Pvt Ltd)., Medikonda Nutrients, Renown Pharmaceuticals Pvt. Ltd., Bolivac Pharmaceutical, Arion Healthcare, Iscon Life Sciences., among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-